Rejoyn is the first and only prescription app for the treatment of major depressive disorder symptoms. It helps tap into the brain's natural ability to change (known as neuroplasticity) with 6 weeks of proven brain-training exercises and short skills-based therapy lessons. At SXSW 2025, Rejoyn is the sponsor of the Health & Wellness Pavilion for the SXSW Expo.

INDICATION:  Rejoyn is a prescription digital therapeutic for the treatment of Major Depressive Disorder (MDD) symptoms as an adjunct to clinician-managed outpatient care for adult patients with MDD age 22 years and older who are on antidepressant medication. It is intended to reduce MDD symptoms.

SAFETY INFORMATION:  Rejoyn is not intended to be used as a standalone treatment. Rejoyn does not replace your current medication, including medication for treatment of MDD. You should continue your current treatment as directed by your healthcare provider. Rejoyn cannot send alerts or warnings to your healthcare provider. If you feel that your depression symptoms are worsening or if you have feelings or thoughts of harming yourself or others, please contact your healthcare provider, dial 911, or go to the nearest emergency room immediately.

See patient instruction for use: https://www.rejoyn.com/Patient-Instructions-for-Use.pdf